Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
Hand-out
Press Releases
November 19, 2024

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Phase 3 clinical study of HyBryte™ in CTCL initiating in 2024

bradford

The Bradford Era

Local & Social